Reply: Effects of Cardiac Amyloidosis and Screening Approach on Left Atrial Thrombus Prevalence in Atrial Fibrillation

Free article

Comment

Antony Lurie et al. J Am Coll Cardiol. 2021.

Free article

. 2021 Sep 28;78(13):e91-e92.

doi: 10.1016/j.jacc.2021.07.037.

No abstract available

Comment on

Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.
Lurie A, Wang J, Hinnegan KJ, McIntyre WF, Belley-Côté EP, Amit G, Healey JS, Connolly SJ, Wong JA. Lurie A, et al. J Am Coll Cardiol. 2021 Jun 15;77(23):2875-2886. doi: 10.1016/j.jacc.2021.04.036. J Am Coll Cardiol. 2021. PMID: 34112315
Cardiac Amyloidosis in Patients With Persistent Left Atrial Thrombus.
El-Am EA, Ahmad A, Dispenzieri A, Grogan M, Nkomo VT. El-Am EA, et al. J Am Coll Cardiol. 2021 Sep 28;78(13):e87. doi: 10.1016/j.jacc.2021.06.051. J Am Coll Cardiol. 2021. PMID: 34556326 No abstract available.
Mind the Denominator: Toward a Better Estimate of Prevalence!
Alqarawi W, Ramirez FD, Birnie DH, Sadek MM. Alqarawi W, et al. J Am Coll Cardiol. 2021 Sep 28;78(13):e89-e90. doi: 10.1016/j.jacc.2021.06.052. J Am Coll Cardiol. 2021. PMID: 34556327 No abstract available.